Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Greene (Dublin, Ireland). COPD – will new insights into molecular pathology define new therapies?. Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD

Member's Comments

No comment yet.

Related content which might interest you: COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 The consequences of novel insights into the pathophysiology of asthma for its treatment Source: Annual Congress 2008 - Should asthma no longer be considered an allergic disease? Year: 2008 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Chronic cough: new insights and future prospects Source: Eur Respir Rev, 30 (162) 210127; 10.1183/16000617.0127-2021 Year: 2021 What are the knowledge gaps in COPD that prevent new drug development? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease” Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Using population insight studies to define effective prevention and identification interventions in COPD Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care Year: 2011 Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies? Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021 Year: 2022 Clinical implications of the new concepts regarding COPD pathophysiology Source: Annual Congress 2008 - New insights into COPD pathophysiology Year: 2008 New genetics and epigenetics insights in paediatric asthma Source: International Congress 2017 – Omics in paediatric asthma and beyond Year: 2017 Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 The new horizons of molecular diagnosis: do we still need conventional microbiology? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Latest insights into treatment of small airways diseases Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019 Pathogenesis of lung cancer signalling pathways: roadmap for therapies Source: Eur Respir J 2009; 33: 1485-1497 Year: 2009